Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CSO

SVP, Strategy & External Aff.

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is headquartered in South San Francisco, California.

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therap...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-08-15	Premium	gifted	Premium	Premium	Premium	-
2023-07-20	Premium	acquired	Premium	Premium	Premium	-
2023-02-06	Premium	sold	Premium	Premium	Premium	-
2023-02-03	Premium	sold	Premium	Premium	Premium	-
2023-02-02	Premium	sold	Premium	Premium	Premium	-
2023-02-01	Premium	sold	Premium	Premium	Premium	-
2023-01-31	Premium	sold	Premium	Premium	Premium	-
2023-01-30	Premium	sold	Premium	Premium	Premium	-
2023-01-25	Premium	sold	Premium	Premium	Premium	-
2023-01-24	Premium	sold	Premium	Premium	Premium	-
2023-01-23	Premium	sold	Premium	Premium	Premium	-
2023-01-17	Premium	sold	Premium	Premium	Premium	-
2023-01-13	Premium	sold	Premium	Premium	Premium	-
2023-01-12	Premium	sold	Premium	Premium	Premium	-
2023-01-06	Premium	sold	Premium	Premium	Premium	-
2023-01-05	Premium	sold	Premium	Premium	Premium	-
2023-01-04	Premium	sold	Premium	Premium	Premium	-
2023-01-03	Premium	sold	Premium	Premium	Premium	-
2022-12-29	Premium	sold	Premium	Premium	Premium	-
2022-11-10	Premium	acquired	Premium	Premium	Premium	CEO
2022-10-18	Premium	gifted	Premium	Premium	Premium	-
2022-10-04	Premium	sold	Premium	Premium	Premium	-
2022-10-03	Premium	sold	Premium	Premium	Premium	-
2022-06-23	Premium	acquired	Premium	Premium	Premium	President and CSO
2022-03-21	Premium	bought	Premium	Premium	Premium	-

KZR - Kezar Life Sciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for KZR